EW Q1 2017 Earnings — Edwards Lifesciences Corporation Revenue & Financial Results | Market Cap Arena

EWEdwards Lifesciences Corporation

$49B

Q1 2017 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$884M+26.7% YoY

Gross Profit

$665M75.3% margin

Operating Income

$308M34.8% margin

Net Income

$230M26.1% margin

EPS (Diluted)

$0.35

QoQ Revenue Growth

+15.1%

Cash Flow

Operating Cash Flow

$128M

Free Cash Flow

$110M

Stock-Based Comp.

$15M

Balance Sheet

Total Assets

$4.8B

Total Liabilities

$2.0B

Stockholders' Equity

$2.7B

Cash & Equivalents

$819M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$884M	$697M	+26.7%
Gross Profit	$665M	$517M	+28.7%
Operating Income	$308M	$202M	+52.4%
Net Income	$230M	$143M	+61.0%

Revenue Segments

Transcatheter Heart Valves

$539M61%

Surgical Heart Valve Therapy

$200M23%

Critical Care

$145M16%

Geographic Segments

UNITED STATES

$465M53%

Europe

$261M30%

JAPAN

$79M9%

Rest of World

$79M9%